1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Biopharmaceutical Analysis & Statistics, May 2017 (p3)

Biopharmaceutical Analysis & Statistics, May 2017 (p3)

24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

61-90 of about 700 reports

Purchase Reports From Reputable Market Research Publishers

Biotechnology Products Industry Industry Forecasts - China Focus

  • $ 1800
  • Industry report
  • May 2017
  • by Asia Market Information & Development Company

This study focuses on China’s Biotechnology Products industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities ...

  • Industries : Biotechnology, Biopharmaceutical, Environmental Services
  • Countries : China

Imiglucerase Sales, Price Analysis, & Sales Forecast - 2017

  • $ 1100
  • Industry report
  • April 2017
  • by Fore Pharma

Fore Pharma has released its new research, Imiglucerase Sales, Price Analysis, & Sales Forecast – 2017. Find out the sales of Imiglucerase worldwide and by countries in North America, Europe, Japan, ...

  • Industries : Biopharmaceutical
  • Countries : World

Darbepoetin Alfa Sales, Price Analysis, & Sales Forecast - 2017

  • $ 1100
  • Industry report
  • April 2017
  • by Fore Pharma

Fore Pharma has released its new research, Darbepoetin Alfa Sales, Price Analysis, & Sales Forecast – 2017. Find out the sales of Darbepoetin Alfa worldwide and by countries in North America, Europe, ...

  • Industries : Biopharmaceutical
  • Countries : World

Alteplase Sales, Price Analysis, & Sales Forecast - 2017

  • $ 1100
  • Industry report
  • April 2017
  • by Fore Pharma

Fore Pharma has released its new research, Alteplase Sales, Price Analysis, & Sales Forecast – 2017. Find out the sales of Alteplase worldwide and by countries in North America, Europe, Japan, BRIC, ...

  • Industries : Biopharmaceutical
  • Countries : World

Tenecteplase Sales, Price Analysis, & Sales Forecast - 2017

  • $ 1100
  • Industry report
  • April 2017
  • by Fore Pharma

Fore Pharma has released its new research, Tenecteplase Sales, Price Analysis, & Sales Forecast – 2017. Find out the sales of Tenecteplase worldwide and by countries in North America, Europe, Japan, ...

  • Industries : Biopharmaceutical
  • Countries : World

Moroctocog Alfa Sales, Price Analysis, & Sales Forecast - 2017

  • $ 1100
  • Industry report
  • April 2017
  • by Fore Pharma

Fore Pharma has released its new research, Moroctocog Alfa Sales, Price Analysis, & Sales Forecast – 2017. Find out the sales of Moroctocog Alfa worldwide and by countries in North America, Europe, ...

  • Industries : Biopharmaceutical
  • Countries : World

Human Menopausal Gonadotrophin Sales, Price Analysis, & Sales Forecast - 2017

  • $ 1100
  • Industry report
  • April 2017
  • by Fore Pharma

Fore Pharma has released its new research, Human Menopausal Gonadotrophin Sales, Price Analysis, & Sales Forecast – 2017. Find out the sales of Human Menopausal Gonadotrophin worldwide and by countries ...

  • Industries : Biopharmaceutical
  • Countries : World

Somatropin Sales, Price Analysis, & Sales Forecast - 2017

  • $ 1100
  • Industry report
  • April 2017
  • by Fore Pharma

Fore Pharma has released its new research, Somatropin Sales, Price Analysis, & Sales Forecast – 2017. Find out the sales of Somatropin worldwide and by countries in North America, Europe, Japan, BRIC, ...

  • Industries : Biopharmaceutical
  • Countries : World

Luteinising Hormone / Follicle-Stimulating Hormone Sales, Price Analysis, & Sales Forecast - 2017

  • $ 1100
  • Industry report
  • April 2017
  • by Fore Pharma

Fore Pharma has released its new research, Luteinising Hormone / Follicle-Stimulating Hormone Sales, Price Analysis, & Sales Forecast – 2017. Find out the sales of Luteinising Hormone / Follicle-Stimulating ...

  • Industries : Biopharmaceutical
  • Countries : World

Chorionic Gonadotrophin Sales, Price Analysis, & Sales Forecast - 2017

  • $ 1100
  • Industry report
  • April 2017
  • by Fore Pharma

Fore Pharma has released its new research, Chorionic Gonadotrophin Sales, Price Analysis, & Sales Forecast – 2017. Find out the sales of Chorionic Gonadotrophin worldwide and by countries in North America, ...

  • Industries : Biopharmaceutical
  • Countries : World

Factor VIII Sales, Price Analysis, & Sales Forecast - 2017

  • $ 1100
  • Industry report
  • April 2017
  • by Fore Pharma

Fore Pharma has released its new research, Factor VIII Sales, Price Analysis, & Sales Forecast – 2017. Find out the sales of Factor VIII worldwide and by countries in North America, Europe, Japan, BRIC, ...

  • Industries : Biopharmaceutical
  • Countries : World

Factor VIII / Von Willebrand factor Sales, Price Analysis, & Sales Forecast - 2017

  • $ 1100
  • Industry report
  • April 2017
  • by Fore Pharma

Fore Pharma has released its new research, Factor VIII / Von Willebrand factor Sales, Price Analysis, & Sales Forecast – 2017. Find out the sales of Factor VIII / Von Willebrand factor worldwide and ...

  • Industries : Biopharmaceutical
  • Countries : World

Factor VIII Inhibitor Bypassing Fraction Sales, Price Analysis, & Sales Forecast - 2017

  • $ 1100
  • Industry report
  • April 2017
  • by Fore Pharma

Fore Pharma has released its new research, Factor VIII Inhibitor Bypassing Fraction Sales, Price Analysis, & Sales Forecast – 2017. Find out the sales of Factor VIII Inhibitor Bypassing Fraction worldwide ...

  • Industries : Biopharmaceutical
  • Countries : World

Factor IX Sales, Price Analysis, & Sales Forecast - 2017

  • $ 1100
  • Industry report
  • April 2017
  • by Fore Pharma

Fore Pharma has released its new research, Factor IX Sales, Price Analysis, & Sales Forecast – 2017. Find out the sales of Factor IX worldwide and by countries in North America, Europe, Japan, BRIC, ...

  • Industries : Biopharmaceutical
  • Countries : World

The 2018-2023 World Outlook for Nucleic Acid Isolation and Purification

  • $ 995
  • Industry report
  • April 2017
  • by ICON Group

This study covers the world outlook for nucleic acid isolation and purification across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry ...

  • Industries : Biopharmaceutical

The 2018-2023 World Outlook for Biosimilar Drugs

  • $ 995
  • Industry report
  • April 2017
  • by ICON Group

This study covers the world outlook for biosimilar drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo ...

  • Industries : Biopharmaceutical

The 2018-2023 World Outlook for Biopharmaceuticals

  • $ 995
  • Industry report
  • April 2017
  • by ICON Group

This study covers the world outlook for biopharmaceuticals across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo ...

  • Industries : Biopharmaceutical

The 2018-2023 World Outlook for Biosimilars

  • $ 995
  • Industry report
  • April 2017
  • by ICON Group

This study covers the world outlook for biosimilars across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ...

  • Industries : Biopharmaceutical

The 2018-2023 World Outlook for Biosimilars and Related Biologics

  • $ 995
  • Industry report
  • April 2017
  • by ICON Group

This study covers the world outlook for biosimilars and related biologics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings ...

  • Industries : Biopharmaceutical

Global Blood Plasma Market: Industry Analysis & Outlook (2017-2021)

  • $ 800
  • Industry report
  • May 2017
  • by Koncept Analytics

Plasma is obtained from blood after separation from red blood cells, white blood cells and platelets. The major components of blood plasma include proteins, amino acids, and other essential nutrients. ...

  • Industries : Blood Supply, Tissue Banking and Transplantation, Healthcare
  • Countries : World

Navidea Biopharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • May 2017
  • by MarketLine

Navidea Biopharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Navidea Biopharmaceuticals, Inc. Mergers & Acquisitions (M&A), Partnerships ...

  • Industries : Biopharmaceutical

Arbutus Biopharma Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • May 2017
  • by MarketLine

Arbutus Biopharma Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Arbutus Biopharma Corporation Mergers & Acquisitions (M&A), Partnerships ...

  • Industries : Biopharmaceutical

Novo Nordisk A/S - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • May 2017
  • by MarketLine

Novo Nordisk A/S - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Novo Nordisk A/S Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments ...

  • Industries : Therapy
  • Countries : United States, North America, World, Europe

XTL Biopharmaceuticals Ltd (XTLB) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • May 2017
  • by GlobalData

Summary XTL Biopharmaceuticals Ltd (XTL) is a biopharmaceutical company that offers acquisition, development and commercialization of pharmaceutical products and formulations. The company’s pipeline ...

  • Industries : Biopharmaceutical

Can-Fite BioPharma Ltd (CANF) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • May 2017
  • by GlobalData

Summary Can-Fite BioPharma Ltd (Can-Fite) is a biopharmaceutical company that concentrates on the discovery and clinical development of drugs. The company’s pipeline product portfolio comprise CF101, ...

  • Industries : Biopharmaceutical

ARCA biopharma Inc (ABIO) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • May 2017
  • by GlobalData

Summary ARCA biopharma Inc (ARCA), formerly Nuvelo Inc, is a biopharmaceutical company. The company focuses on the development of genetically targeted therapies for cardiovascular diseases. Its product ...

  • Industries : Biopharmaceutical

Vitro Biopharma (VODG) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • May 2017
  • by GlobalData

Summary Vitro Biopharma (Vitro) is a biopharmaceutical company that develops and commercializes adult stem cell products. The company’s products include cell culture media, cell lines, and cell measurement ...

  • Industries : Biopharmaceutical

Theravance Biopharma Inc (TBPH) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • May 2017
  • by GlobalData

Summary Theravance Biopharma Inc (Theravance) which discovers and develops novel medicines for the treatment of various diseases. Its product include telavancin, which is a dual mechanism antibiotic. The ...

  • Industries : Biopharmaceutical

Alliqua BioMedical Inc (ALQA) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • May 2017
  • by GlobalData

Summary Alliqua BioMedical Inc (Alliqua BioMedical) formerly HepaLife Technologies Inc. is a medical device company that offers wound care solutions. The company offers wound care, transdermal drug delivery, ...

  • Industries : Biopharmaceutical

Xbrane Biopharma AB (XBRANE) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • May 2017
  • by GlobalData

Summary Xbrane Biopharma AB (Xbrane), formerly known as Xbrane Bioscience AB, is a biopharmaceutical company that develops and manufactures complex generics. The company’s product portfolio includes ...

  • Industries : Biopharmaceutical

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.